Giorgio Ottaviano

10PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthInnate immunityNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 30, 2026
Immunotherapy refractoriness and early post-alloHCT relapse define ultra-high-risk B-ALL after CD19 CAR T-cell therapy.

|Jul 01, 2026
Outcomes of invasive fungal infections in 358 children undergoing allogeneic haematopoietic stem cell transplantation: A prospective UK study.

|Sep 03, 2025
Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group.

Taymour Hammoudi, Silvia Nucera, Alexandre G Troullioud Lucas

|Apr 08, 2025
Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapy.

Giorgio Ottaviano, Waseem Qasim

|Oct 26, 2022
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia.

Giorgio Ottaviano, Christos Georgiadis, Soragia Athina Gkazi

|Jul 27, 2022
Secondary rituximab-associated versus primary immunodeficiencies: The enigmatic border.

Giorgio Ottaviano, Mayla Sgrulletti, Viviana Moschese

Pageof 2

Frequent Collaborators

2 joint publications

Adriana Cristina Balduzzi

2 joint publications

Waseem Qasim

1 joint publications

Juliana M Furtado-Silva

1 joint publications

Rachel Hough